192 related articles for article (PubMed ID: 30145840)
1. Subacute treatment of carprofen facilitate splenocardiac resolution deficit in cardiac injury.
Halade GV; Kain V; Wright GM; Jadapalli JK
J Leukoc Biol; 2018 Dec; 104(6):1173-1186. PubMed ID: 30145840
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment of carprofen impaired initiation of inflammatory- and overlapping resolution response and promoted cardiorenal syndrome in heart failure.
Krishnan V; Booker D; Cunningham G; Jadapalli JK; Kain V; Pullen AB; Halade GV
Life Sci; 2019 Feb; 218():224-232. PubMed ID: 30597172
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of FPR2 impaired leukocytes recruitment and elicited non-resolving inflammation in acute heart failure.
Kain V; Jadapalli JK; Tourki B; Halade GV
Pharmacol Res; 2019 Aug; 146():104295. PubMed ID: 31216426
[TBL] [Abstract][Full Text] [Related]
4. Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure.
Halade GV; Kain V; Serhan CN
FASEB J; 2018 Jul; 32(7):3717-3729. PubMed ID: 29455574
[TBL] [Abstract][Full Text] [Related]
5. Lipoxygenase inhibitor ML351 dysregulated an innate inflammatory response leading to impaired cardiac repair in acute heart failure.
Tourki B; Black LM; Kain V; Halade GV
Biomed Pharmacother; 2021 Jul; 139():111574. PubMed ID: 33862495
[TBL] [Abstract][Full Text] [Related]
6. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
[TBL] [Abstract][Full Text] [Related]
7. Activation of EP4 receptor limits transition of acute to chronic heart failure in lipoxygenase deficient mice.
Kain V; Ingle KA; Rajasekaran NS; Halade GV
Theranostics; 2021; 11(6):2742-2754. PubMed ID: 33456570
[No Abstract] [Full Text] [Related]
8. Metabolic transformation of fat in obesity determines the inflammation resolving capacity of splenocardiac and cardiorenal networks in heart failure.
Halade GV; Kain V; De La Rosa X; Lindsey ML
Am J Physiol Heart Circ Physiol; 2022 Jun; 322(6):H953-H970. PubMed ID: 35333119
[TBL] [Abstract][Full Text] [Related]
9. IL-33 induces type-2-cytokine phenotype but exacerbates cardiac remodeling post-myocardial infarction with eosinophil recruitment, worsened systolic dysfunction, and ventricular wall rupture.
Ghali R; Habeichi NJ; Kaplan A; Tannous C; Abidi E; Bekdash A; Farhat R; Itani H; Jurjus A; Booz GW; Mallat Z; Zouein FA
Clin Sci (Lond); 2020 Jun; 134(11):1191-1218. PubMed ID: 32432676
[TBL] [Abstract][Full Text] [Related]
10. Interaction of 12/15-lipoxygenase with fatty acids alters the leukocyte kinetics leading to improved postmyocardial infarction healing.
Halade GV; Kain V; Ingle KA; Prabhu SD
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H89-H102. PubMed ID: 28411230
[TBL] [Abstract][Full Text] [Related]
11. Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction.
Kain V; Ingle KA; Kabarowski J; Barnes S; Limdi NA; Prabhu SD; Halade GV
J Mol Cell Cardiol; 2018 May; 118():70-80. PubMed ID: 29526491
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin triggers splenic contraction and irreversible dysregulation of COX and LOX that alters the inflammation-resolution program in the myocardium.
Jadapalli JK; Wright GW; Kain V; Sherwani MA; Sonkar R; Yusuf N; Halade GV
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1091-H1100. PubMed ID: 30074834
[TBL] [Abstract][Full Text] [Related]
13. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype.
Horckmans M; Ring L; Duchene J; Santovito D; Schloss MJ; Drechsler M; Weber C; Soehnlein O; Steffens S
Eur Heart J; 2017 Jan; 38(3):187-197. PubMed ID: 28158426
[TBL] [Abstract][Full Text] [Related]
14. Resolution Agonist 15-epi-Lipoxin A
Kain V; Liu F; Kozlovskaya V; Ingle KA; Bolisetty S; Agarwal A; Khedkar S; Prabhu SD; Kharlampieva E; Halade GV
Sci Rep; 2017 Aug; 7(1):9999. PubMed ID: 28855632
[TBL] [Abstract][Full Text] [Related]
15. Arachidonate 5-lipoxygenase is essential for biosynthesis of specialized pro-resolving mediators and cardiac repair in heart failure.
Halade GV; Kain V; Hossain S; Parcha V; Limdi NA; Arora P
Am J Physiol Heart Circ Physiol; 2022 Oct; 323(4):H721-H737. PubMed ID: 36018758
[TBL] [Abstract][Full Text] [Related]
16. Splenic Ly6C
Tomczyk M; Kraszewska I; Szade K; Bukowska-Strakova K; Meloni M; Jozkowicz A; Dulak J; Jazwa A
Basic Res Cardiol; 2017 Jul; 112(4):39. PubMed ID: 28534119
[TBL] [Abstract][Full Text] [Related]
17. Molecular and Cellular Differences in Cardiac Repair of Male and Female Mice.
Pullen AB; Kain V; Serhan CN; Halade GV
J Am Heart Assoc; 2020 Apr; 9(8):e015672. PubMed ID: 32295449
[TBL] [Abstract][Full Text] [Related]
18. Interaction of aging with lipoxygenase deficiency initiates hypersplenism, cardiac dysfunction, and profound leukocyte directed non-resolving inflammation.
Kain V; Mat Y; Halade GV
Geroscience; 2022 Jun; 44(3):1689-1702. PubMed ID: 34932185
[TBL] [Abstract][Full Text] [Related]
19. Macrophage Specific Lipoxygenase Deletion Amplify Cardiac Repair Activating Tregs in Chronic Heart Failure.
Kain V; Grilo GA; Upadhyay G; Nadler JL; Serhan CN; Halade GV
J Leukoc Biol; 2024 May; ():. PubMed ID: 38785336
[TBL] [Abstract][Full Text] [Related]
20. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
Iyer RP; de Castro Brás LE; Patterson NL; Bhowmick M; Flynn ER; Asher M; Cannon PL; Deleon-Pennell KY; Fields GB; Lindsey ML
J Mol Cell Cardiol; 2016 Nov; 100():109-117. PubMed ID: 27746126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
